Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.
Gnann JW Jr, Crumpacker CS, Lalezari JP, Smith JA, Tyring SK, Baum KF, Borucki MJ, Joseph WP, Mertz GJ, Steigbigel RT, Cloud GA, Soong SJ, Sherrill LC, DeHertogh DA, Whitley RJ. Gnann JW Jr, et al. Among authors: mertz gj. Antimicrob Agents Chemother. 1998 May;42(5):1139-45. doi: 10.1128/AAC.42.5.1139. Antimicrob Agents Chemother. 1998. PMID: 9593141 Free PMC article. Clinical Trial.
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, Schleupner CJ, Hayden F, Wolf J, Soong SJ. Whitley RJ, et al. Among authors: mertz gj. Ann Intern Med. 1996 Sep 1;125(5):376-83. doi: 10.7326/0003-4819-125-5-199609010-00004. Ann Intern Med. 1996. PMID: 8702088 Clinical Trial.
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.
Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ; Collaborative Antiviral Study Group. Mertz GJ, et al. Clin Infect Dis. 2004 Nov 1;39(9):1307-13. doi: 10.1086/425007. Epub 2004 Oct 11. Clin Infect Dis. 2004. PMID: 15494907 Clinical Trial.
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group. Corey L, et al. N Engl J Med. 2004 Jan 1;350(1):11-20. doi: 10.1056/NEJMoa035144. N Engl J Med. 2004. PMID: 14702423 Free article. Clinical Trial.
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome.
Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ; Ribavirin Study Group. Chapman LE, et al. Among authors: mertz gj. Clin Infect Dis. 2002 Feb 1;34(3):293-304. doi: 10.1086/324619. Epub 2001 Dec 13. Clin Infect Dis. 2002. PMID: 11774075 Clinical Trial.
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.
Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF. Chapman LE, et al. Among authors: mertz gj. Antivir Ther. 1999;4(4):211-9. doi: 10.1177/135965359900400404. Antivir Ther. 1999. PMID: 10723500 Clinical Trial.
91 results